Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Tran M. Nguyen"'
Autor:
Tran M. Nguyen, Matt Downs, Neil Bennett, Vitaliy Matyushenko, Harumasa Nakamura, Damjan Osredkar, Shiwen Wu, Nathalie Goemans, Anna Ambrosini, Rahsa El Sherifc, Craig Campbell
Publikováno v:
Journal of Rare Diseases Research & Treatment. 7:5-15
Background: TREAT-NMD is a global neuromuscular (NM) organization, created to enhance infrastructure to facilitate novel therapeutics reaching patients. One main activity is aimed at supporting NM disease registries. These rare disease registries are
Autor:
Sudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, Tim Raine, Nurulamin M Noor, Neeraj Narula, Bram Verstockt, Brian G Feagan, Siddharth Singh, Christopher Ma, Vipul Jairath
Publikováno v:
Inflammatory Bowel Diseases.
Background Precise estimates of placebo response rates help efficient clinical trial design. In this systematic review and meta-analysis, we assessed contemporary placebo endoscopic and histological response rates in Crohn’s disease (CD) clinical t
Autor:
Sudheer K. Vuyyuru, Florian Rieder, Virginia Solitano, Tran M. Nguyen, Eileen Crowley, Neeraj Narula, Siddharth Singh, Christopher Ma, Vipul Jairath
Publikováno v:
American Journal of Gastroenterology.
Autor:
Geert R. D'Haens, Florian Rieder, Rocio Sedano, Tran M Nguyen, Ahmed Almradi, Claire E Parker, Brian G. Feagan, Christopher Ma, Lisa M. Shackelton, William J. Sandborn, Vipul Jairath
Publikováno v:
Inflamm Bowel Dis
Background Several indices exist to measure pouchitis disease activity; however, none are fully validated. As an initial step toward creating a validated instrument, we identified pouchitis disease activity indices, examined their operating propertie
Autor:
Mark E. Baker, Reetesh K. Pai, Paula Borralho, Roger Feakins, Brian G. Feagan, Arne Bokemeyer, William J. Sandborn, Noam Harpaz, Leonardo Guizzetti, Florian Rieder, Rish K. Pai, Marie E. Robert, Amitabh Srivastava, David H. Bruining, Mark A. Valasek, Christophe Rosty, Tran M Nguyen, Gert De Hertogh, Lisa M. Shackelton, Vipul Jairath, Ilyssa O. Gordon, Joel G. Fletcher, Ren Mao, Dominik Bettenworth, Claire E Parker, Robert D. Odze, Jiannan Li
Publikováno v:
Gut
ObjectiveEffective medical therapy and validated trial outcomes are lacking for small bowel Crohn’s disease (CD) strictures. Histopathology of surgically resected specimens is the gold standard for correlation with imaging techniques. However, no v
Autor:
Pavine Lefevre, Bryan Linggi, Tran M Nguyen, John K MacDonald, Niels Vande Casteele, Yinghong Wang, Brian G. Feagan, Vipul Jairath, Christopher Ma
Publikováno v:
Digestive Diseases and Sciences. 67:1128-1155
Patients treated with immune checkpoint inhibitors (ICIs) may develop ICI-associated enterocolitis, for which there is no approved treatment. We aimed to systematically review the efficacy and safety of medical interventions for the prevention and tr
Autor:
Jane M. Andrews, Claire E Parker, Thomas M Goodsall, Robert V Bryant, Tran M Nguyen, Vipul Jairath, Christopher Ma
Publikováno v:
Journal of Crohn's and Colitis. 15:125-142
Background and Aims Serial measurements of luminal disease activity may facilitate inflammatory bowel disease management. Gastrointestinal ultrasound is an easily performed, non-invasive alternative to other assessment modes. However, its widespread
Autor:
Thomas M Goodsall, Tran M Nguyen, Robert V Bryant, Samuel P Costello, Richard Noy, Vipul Jairath
Publikováno v:
Journal of the Canadian Association of Gastroenterology
Background and Aims Inflammatory bowel disease (IBD) is a lifelong disease requiring frequent assessment to guide treatment and prevent flares or progression. Multiple tools are available for clinicians to monitor disease activity; however, there are
Systematic review: disease activity indices for immune checkpoint inhibitor-associated enterocolitis
Autor:
Joshua Chang, Brian G. Feagan, Niels Vande Casteele, Vipul Jairath, John K MacDonald, Christopher Ma, Tran M Nguyen
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 55(2)
BACKGROUND Although there is interest in developing pharmacotherapies for the treatment of immune checkpoint inhibitor-associated enterocolitis (ICIC), there is currently no consensus on how to optimally measure disease activity in this condition. AI
Autor:
Emilio Merlo Pich, Maria Grimaldi, Joshua Chang, Malcolm Hogan, Alessandro Ble, John K MacDonald, Michelangelo Barone, Christopher Ma, Brian G. Feagan, Cecilia Renzulli, Rocio Sedano, Tran M Nguyen, Guangyong Zou, William J. Sandborn, Vipul Jairath, Fabio Cenci
Publikováno v:
J Crohns Colitis
Background and Aims We aimed to quantify the magnitude of the association between endoscopic recurrence and clinical recurrence [symptom relapse] in patients with postoperative Crohn’s disease. Methods Databases were searched to October 2, 2020, fo